Review Papers Claim by Claim

Concise appraisal (visual → explanation)

1. Scope & methodology: The authors performed a systematic search across PubMed, Web of Science, Cochrane Library and Google Scholar for articles published Jan 2019–Apr 2025 and screened 1,864 records to include 50 studies; selection and screening was dual-reviewed with a third reviewer for disputes, and inclusion required deep‑learning based multi‑modal fusion applied to human breast cancer tasks Search & selection description (Li et al. 2025)
2. Organization and clarity: The paper constructs a clear taxonomy — feature‑level (single/multi‑layer, homogeneous/heterogeneous), decision‑level (averaging, voting, weighted, fuzzy integrals), and hybrid (attention, cross‑modal autoencoders, graph‑based) — with schematic frameworks and multiple case examples (tables with representative papers and metrics) Fusion taxonomy and datasets (Li et al. 2025)
3. Strengths:
   • Comprehensive, recent coverage (up to Apr 2025) and practical organization for ML researchers/clinicians.
   • Useful catalog of public datasets and links (TCGA, METABRIC, TCIA/CBIS‑DDSM, BreakHis) and typical preprocessing pipelines (feature selection, ROI extraction, normalization, one‑hot encoding) Datasets & preprocessing (Li et al. 2025).
4. Weaknesses & blindspots:
   • No formal risk-of-bias or quality scoring of the 50 included primary studies (QUADAS-2/PROBAST absent) — reduces ability to weigh evidence quantitatively.
   • Search included Google Scholar (good sensitivity) but the methods do not report a full reproducible search string or PRISMA flow dataset export; reproducibility would improve if search strings and extracted dataset (CSV) were published Methods transparency note (Li et al. 2025).
   • English-only inclusion and no formal assessment of publication bias or small-study effects; risks optimistic effect summaries (positive‑result bias) — acknowledged but not quantified.
   • Comparisons across fusion strategies are mostly narrative and example‑based (tables with selected AUC/ACC). There is no meta-analysis controlling for dataset, task, or backbone network; therefore claims that feature/hybrid fusion > decision fusion are plausible but not proven across tasks/datasets Performance evidence caveat (Li et al. 2025).
5. Reproducibility: The review lists datasets and many primary papers but does not provide a machine‑readable extraction table, search strings, or a code repository for reproducing the survey counts; reproducibility score is therefore moderate (Reproducibility limitation (Li et al. 2025)).
6. Conflict-of-interest & funding transparency: Funding is multiple (Chinese national grants and institutional) and declared; conflict‑of‑interest statement is not detailed beyond 'authors accountable' — advisable to include explicit COI/affiliations for all included study assessments Funding statement (Li et al. 2025).

Practical takeaways for researchers

• When designing multi‑modal models, prefer modular architectures (heterogeneous backbones for modality-specific encoders) and attention or graph mechanisms for alignment across heterogeneous distributions; these appear repeatedly among high‑performing examples cited in the review Recommended architectures (Li et al. 2025).
• Prioritize dataset curation: match modalities, synchronize acquisition timepoints (especially for longitudinal NST or risk models), and publish preprocessing pipelines (normalization, ROI, stain normalization) and seeds to enable reproducibility.
• Use federated learning and synthetic-data generators (GANs/diffusion) only as supplements; emphasize external, multi‑center validation to check generalizability and avoid overfitting to private datasets Federated & generative recommendation (Li et al. 2025).

Where the paper could be stronger (concrete)

1. Publish the extraction table (CSV/JSON) with study-level fields (modalities, datasets, sample sizes, metrics, code links, hardware) to enable reanalysis and quantitative meta‑study.
2. Perform a formal bias assessment (QUADAS‑2/PROBAST) and present sensitivity analyses (e.g., restrict to external‑validated studies; subgroup by dataset like METABRIC/TCGA) to move from narrative to evidence‑weighted conclusions.
3. Provide full reproducible search strings and ideally a GitHub repo with scripts used to count and classify papers.

Confidence and final verdict

This is a high‑value narrative review (useful for newcomers and practitioners) that synthesizes 2019–2025 literature and provides a practical taxonomy and recommendations for multi‑modal fusion in breast cancer. Its conclusions are plausible and well‑motivated but should be interpreted qualitatively because no pooled meta‑analysis, risk‑of‑bias assessment, or public extraction dataset was provided — so confidence in universal superiority of any fusion family (feature/hybrid) should be moderate until multi‑center quantitative comparisons appear Conclusions caution (Li et al. 2025).

Author review links (one-click)